CARLO ROMANO

Dr. CARLO ROMANO

STUDIO MEDICO ASSOCIATO CECCA-ROMANO
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
CRCARLO ROMANO
CARLO ROMANO
SSSara Scarponi
Sara Scarponi
EGEnrico Gallazzi
Enrico Gallazzi
DRDelia Romanò
Delia Romanò
Lorenzo DragoLorenzo Drago
Lorenzo Drago
Implanted biomaterials play a key role in current success of orthopedic and trauma surgery. However, implant-related infections remain among the leading reasons for failure with high economical and social associated costs. According to the current knowledge, probably the most critical pathogenic event in the development of implant-related infection is biofilm formation, which starts immediately after bacterial adhesion on an implant and effectively protects the microorganisms from the immune system and systemic antibiotics. A rationale, modern prevention of biomaterial-associated infections should then specifically focus on inhibition of both bacterial adhesion and biofilm formation. Nonetheless, currently available prophylactic measures, although partially effective in reducing surgical site infections, are not based on the pathogenesis of biofilm-related infections and unacceptable high rates of septic complications, especially in high-risk patients and procedures, are still reported. In the last decade, several studies have investigated the ability of implant surface modifications to minimize bacterial adhesion, inhibit biofilm formation, and provide effective bacterial killing to protect implanted biomaterials, even if there still is a great discrepancy between proposed and clinically implemented strategies and a lack of a common language to evaluate them. To move a step forward towards a more systematic approach in this promising but complicated field, here we provide a detailed overview and an original classification of the various technologies under study or already in the market. We may distinguish the following: 1. Passive surface finishing/modification (PSM): passive coatings that do not release bactericidal agents to the surrounding tissues, but are aimed at preventing or reducing bacterial adhesion through surface chemistry and/or structure modifications; 2. Active surface finishing/modification (ASM): active coatings that feature pharmacologically active pre-incorporated bactericidal agents; and 3. Local carriers or coatings (LCC): local antibacterial carriers or coatings, biodegradable or not, applied at the time of the surgical procedure, immediately prior or at the same time of the implant and around it. Classifying different technologies may be useful in order to better compare different solutions, to improve the design of validation tests and, hopefully, to improve and speed up the regulatory process in this rapidly evolving field.

1 December 2016 in Injury
Verified
Journal Article
Closed access
IMIlaria Morelli
Ilaria Morelli
Lorenzo DragoLorenzo Drago
Lorenzo Drago
DGDavid A. George
David A. George
EGEnrico Gallazzi
Enrico Gallazzi
SSSara Scarponi
Sara Scarponi
CRCARLO ROMANO
CARLO ROMANO

21 January 2012 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
CRCARLO ROMANO
CARLO ROMANO
LGL. Gala
L. Gala
NLNicola Logoluso
Nicola Logoluso
DRD. Romanò
D. Romanò
Lorenzo DragoLorenzo Drago
Lorenzo Drago

1 January 2017 in Journal of Bone and Joint Infection
Verified
Journal Article
Open access
CRCARLO ROMANO
CARLO ROMANO
EVE. De Vecchi
E. De Vecchi
MBM. Bortolin
M. Bortolin
IMIlaria Morelli
Ilaria Morelli
LDL. Drago
L. Drago
Living in biofilms is probably the most common condition for bacteria and fungi and biofilm-related infections account for the majority of bacterial infectious diseases worldwide.Among others biofilm-related infections, those associated with implanted biomaterials have an enormous and still largely underestimated impact in orthopaedics and trauma, cardio-surgery and several other surgical disciplines.Given the limited efficacy of existing antibiotics in the prevention and treatment of bacterial biofilms, new strategies are needed to protect implants and host tissues, overcoming the striking ability of the microorganisms to adhere on different surfaces and to immediately protect themselves by forming the biofilm matrix.Adhesion is a necessary first step in microbial colonization and pathogenesis and provides a potential target for new preventive and treatment approach.Among various polymers, tested as antibacterial coatings, hyaluronic acid and some of its composites do offer a well-established long-term safety profile and a proven ability to reduce bacterial adhesion and biofilm formation.Aim of the present review is to summarize the available evidence concerning the antiadhesion/antibiofilm activity of hyaluronic acid and some of its derivatives to reduce/prevent bacterial adhesion and biofilm formation in various experimental and clinical settings.

13 March 2014 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Open access
PDF file
Lorenzo DragoLorenzo Drago
Lorenzo Drago
WBWillemijn Boot
Willemijn Boot
KDKostantinos Dimas
Kostantinos Dimas
KMKostantinos Malizos
Kostantinos Malizos
GHGertrud M. Hänsch
Gertrud M. Hänsch
CRCARLO ROMANO
CARLO ROMANO
Background Implant-related infections represent one of the most severe complications in orthopaedics. A fast-resorbable, antibacterial-loaded hydrogel may reduce or prevent bacterial colonization and biofilm formation of implanted biomaterials. Questions/purposes We asked: (1) Is a fast-resorbable hydrogel able to deliver antibacterial compounds in vitro? (2) Can a hydrogel (alone or antibacterial-loaded) coating on implants reduce bacterial colonization? And (3) is intraoperative coating feasible and resistant to press-fit implant insertion? Methods We tested the ability of Disposable Antibacterial Coating (DAC) hydrogel (Novagenit Srl, Mezzolombardo, Italy) to deliver antibacterial agents using spectrophotometry and a microbiologic assay. Antibacterial and antibiofilm activity were determined by broth microdilution and a crystal violet assay, respectively. Coating resistance to press-fit insertion was tested in rabbit tibias and human femurs. Results Complete release of all tested antibacterial compounds was observed in less than 96 hours. Bactericidal and antibiofilm effect of DAC hydrogel in combination with various antibacterials was shown in vitro. Approximately 80% of the hydrogel coating was retrieved on the implant after press-fit insertion. Conclusions Implant coating with an antibacterial-loaded hydrogel reduces bacterial colonization and biofilm formation in vitro. Clinical Relevance A fast-resorbable, antibacterial-loaded hydrogel coating may help prevent implant-related infections in orthopaedics. However, further validation in animal models and properly controlled human studies is required.

2 February 2017 in Journal of Orthopaedics and Traumatology
Verified
Journal Article
Open access
PDF file
KMKonstantinos Malizos
Konstantinos Malizos
MBMichael Blauth
Michael Blauth
ADAdrian Danita
Adrian Danita
NCNicola Capuano
Nicola Capuano
RMRiccardo Mezzoprete
Riccardo Mezzoprete
CRCARLO ROMANO
CARLO ROMANO
Background Infection is one of the main reasons for failure of orthopedic implants. Antibacterial coatings may prevent bacterial adhesion and biofilm formation, according to various preclinical studies. The aim of the present study is to report the first clinical trial on an antibiotic-loaded fast-resorbable hydrogel coating (Defensive Antibacterial Coating, DAC®) to prevent surgical site infection, in patients undergoing internal osteosynthesis for closed fractures. Materials and methods In this multicenter randomized controlled prospective study, a total of 256 patients in five European orthopedic centers who were scheduled to receive osteosynthesis for a closed fracture, were randomly assigned to receive antibiotic-loaded DAC or to a control group (without coating). Pre- and postoperative assessment of laboratory tests, wound healing, clinical scores and X-rays were performed at fixed time intervals. Results Overall, 253 patients were available with a mean follow-up of 18.1 ± 4.5 months (range 12–30). On average, wound healing, clinical scores, laboratory tests and radiographic findings did not show any significant difference between the two groups. Six surgical site infections (4.6%) were observed in the control group compared to none in the treated group (P < 0.03). No local or systemic side-effects related to the DAC hydrogel product were observed and no detectable interference with bone healing was noted. Conclusions The use of a fast-resorbable antibiotic-loaded hydrogel implant coating provides a reduced rate of post-surgical site infections after internal osteosynthesis for closed fractures, without any detectable adverse event or side-effects. Level of evidence 2.